One of the nation's top research institutes announced yesterday it had reached a deal to license out a cancer fighting compound extracted from a Chinese herbal medicine, in the hope a private company backed by Koo's Group (
Officials said the compound, extracted from the herb Shan Fang Feng (
"This is a drug lead, not a drug," said Johnsee Lee (李鍾熙), general director of the Biomedical Engineering Center at the Industrial Technology Research Institute (ITRI, 工研院). "Further study is needed before it becomes a real medicine.
"It's not Chinese medicine. It's a compound that we've isolated and extracted from herbs used in traditional Chinese medicine. The compound is what we're working on as a drug lead," he said.
ITRI, a publicly funded R&D center based in Hsinchu, said it has passed the torch for its research into the cancer-fighting compound to the Taiwan-based Synpac-Kingdom Pharmaceutical Co (景德製藥), which is wholly owned by Taiwan-based Koo's Group, a large, family-run conglomerate.
Leslie Koo (
The fight against cancer became personal for the Koo family after the passing of Chester Koo (
Synpac-Kingdom officials say it could take up to eight years to finish all levels of testing. Over the next three years, the company will spend around NT$33.5 million (US$1 million) on pre-clinical drug trials, including testing the cancer fighting compound on animals, according to Eric Chiou (邱翼聰), senior vice president at Synpac.
Research on the compound was the result of a decade-long collaboration between ITRI, the National Taiwan University Hospital, and two research centers in the US, one at Purdue University in West Lafayette, Indiana, and another at the National Cancer Institute.
Together, these groups brought the compound to a level of purity that makes it ready for clinical testing.
Synpac-Kingdom will pay a licensing fee to ITRI for its research. If the compound becomes a medicine in the future, all parties involved in research will be paid licensing fees, Lee said.
The research center decided to license out the technology in order to move it forward a step, as ITRI does not conduct clinical testing.
Synpac-Kingdom is 100 percent owned by the Koo's Group, in large part through its subsidiary China Synthetic Rubber Corp (
Synpac-Kingdom has also invested in a UK-based drugmaker Penicillin G.
BIG BUCKS: Chairman Wei is expected to receive NT$34.12 million on a proposed NT$5 cash dividend plan, while the National Development Fund would get NT$8.27 billion Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday announced that its board of directors approved US$15.25 billion in capital appropriations for long-term expansion to meet growing demand. The funds are to be used for installing advanced technology and packaging capacity, expanding mature and specialty technology, and constructing fabs with facility systems, TSMC said in a statement. The board also approved a proposal to distribute a NT$5 cash dividend per share, based on first-quarter earnings per share of NT$13.94, it said. That surpasses the NT$4.50 dividend for the fourth quarter of last year. TSMC has said that while it is eager
‘IMMENSE SWAY’: The top 50 companies, based on market cap, shape everything from technology to consumer trends, advisory firm Visual Capitalist said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) was ranked the 10th-most valuable company globally this year, market information advisory firm Visual Capitalist said. TSMC sat on a market cap of about US$915 billion as of Monday last week, making it the 10th-most valuable company in the world and No. 1 in Asia, the publisher said in its “50 Most Valuable Companies in the World” list. Visual Capitalist described TSMC as the world’s largest dedicated semiconductor foundry operator that rolls out chips for major tech names such as US consumer electronics brand Apple Inc, and artificial intelligence (AI) chip designers Nvidia Corp and Advanced
Saudi Arabian Oil Co (Aramco), the Saudi state-owned oil giant, yesterday posted first-quarter profits of US$26 billion, down 4.6 percent from the prior year as falling global oil prices undermine the kingdom’s multitrillion-dollar development plans. Aramco had revenues of US$108.1 billion over the quarter, the company reported in a filing on Riyadh’s Tadawul stock exchange. The company saw US$107.2 billion in revenues and profits of US$27.2 billion for the same period last year. Saudi Arabia has promised to invest US$600 billion in the US over the course of US President Donald Trump’s second term. Trump, who is set to touch
SKEPTICAL: An economist said it is possible US and Chinese officials would walk away from the meeting saying talks were productive, without reducing tariffs at all US President Donald Trump hailed a “total reset” in US-China trade relations, ahead of a second day of talks yesterday between top officials from Washington and Beijing aimed at de-escalating trade tensions sparked by his aggressive tariff rollout. In a Truth Social post early yesterday, Trump praised the “very good” discussions and deemed them “a total reset negotiated in a friendly, but constructive, manner.” The second day of closed-door meetings between US Secretary of the Treasury Scott Bessent, US Trade Representative Jamieson Greer and Chinese Vice Premier He Lifeng (何立峰) were due to restart yesterday morning, said a person familiar
RSS